AI Summary
Two Harbors confirms UWMC did not submit a bid during the waiver window and the board urges voting FOR the CCM deal. The all-cash $12.00 per share plus a stub dividend, fully financed, is supported by strong regulatory progress with 46 of 53 approvals secured and an August 2026 close target. The catalyst is the deal’s closing, which should deliver immediate cash to TWO stockholders and reduce exposure to UWMC stock.
Sentiment Rationale
Certainty of all-cash consideration at $12 per share reduces downside if regulatory risk remains manageable; approval progress and financing certainty historically elevate TWO’s stock when a deal nears close.
Trading Thesis
Near-term upside for TWO on deal certainty; expect price to converge toward $12 cash near August 2026.
Market-Moving
- UWMC's failure to bid reduces risk of a competing transaction.
- Financing certainty and regulatory progress bolster CCM close probability.
- TWO may reprice toward the $12 cash offer if the deal remains on track.
- Stock-elect vs cash considerations are no longer a dynamic risk.
Key Facts
- UWMC did not submit a proposal during the waiver period.
- TWO board urges stockholders to vote FOR CCM at the June 23 meeting.
- CCM offers $12.00 per share in cash plus pro-rated stub dividend.
- Waiver period ended June 12; UWMC did not submit revised terms.
- 46 of 53 regulatory approvals secured; closing targeted for August 2026.
Companies Mentioned
- Two Harbors Investment Corp. (TWO): Board recommends FOR the CCM transaction; deal value and timing could drive immediate cash realization.
- UWM Holdings Corporation (UWMC): Did not submit revised proposal during waiver; stock has fallen >50% since Dec 2025; limited bid risk to CCM.
- CrossCountry Mortgage LLC (CCM): Buyer; all-cash consideration with binding financing; primary driver of TWO's near-term value realization.
M&A
Category: M&A. This release centers on a definitive acquisition/merger, financing commitments, and board recommendations, which are key catalysts for TWO's valuation and near-term price path.